SQZ BIOTECH
SQZ Biotech is a developer of a cell engineering technology designed to deliver a diverse set of materials into patient cells. It is a privately held company that develops cellular therapies for multiple indications using the proprietary CellSqueeze technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immune suppression for a wide range of clinical challenges.
SQZ BIOTECH
Industry:
Biotechnology Life Science Therapeutics
Founded:
2013-01-01
Address:
Watertown, Massachusetts, United States
Country:
United States
Website Url:
http://www.sqzbiotech.com
Total Employee:
101+
Status:
Active
Contact:
617-758-8672
Email Addresses:
[email protected]
Total Funding:
229.81 M USD
Technology used in webpage:
Content Delivery Network Amazon HSTS IPv6 Cloudflare Hosting Facebook Sharer Cloudflare CDN ReCAPTCHA V2 Amazon Virginia Region COVID-19
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
National Institute of General Medical Science
National Institute of General Medical Science investment in Grant - SQZ Biotech
Invus
Invus investment in Series D - SQZ Biotech
Polaris Partners
Polaris Partners investment in Series D - SQZ Biotech
Illumina Ventures
Illumina Ventures investment in Series D - SQZ Biotech
JDRF T1D Fund
JDRF T1D Fund investment in Series D - SQZ Biotech
Google Ventures
Google Ventures investment in Series D - SQZ Biotech
+ND Capital
+ND Capital investment in Series D - SQZ Biotech
Nano Dimension
Nano Dimension investment in Series D - SQZ Biotech
Temasek Holdings
Temasek Holdings investment in Series D - SQZ Biotech
Google Ventures
Google Ventures investment in Series D - SQZ Biotech
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-11 | SQZ Biotechnologies Appoints Micah Zajic as Chief Financial Officer |
More informations about "SQZ Biotech"
SQZ Biotech - Crunchbase Company Profile & Funding
SQZ Biotech is a developer of a cell engineering technology designed to deliver a diverse set of materials into patient cells. It is a privately held company that …See details»
SQZ Biotech 2025 Company Profile: Valuation, Investors
SQZ Biotech General Information Description. SQZ Biotechnologies Co is a clinical-stage biotechnology company developing transformative cell therapies for patients with cancer, …See details»
SQZ Biotechnologies Company (SQZB) - Yahoo Finance
See the company profile for SQZ Biotechnologies Company (SQZB) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Where Are They Now? SQZ Biotech
May 1, 2024 In 2020, Sharei took SQZ Biotech public with a $71 million IPO, and channeled the funds into its pipeline of novel cell therapies. Being the founder and CEO of SQZ Biotech was Sharei’s first full-time job, and it was “all …See details»
SQZBiotech - Company Profile - Tracxn
SQZBiotech - Developer of cell therapies to treat multiple diseases. Acquired by Stem Cell Technologies. Raised a total funding of $167M over 12 rounds from 27 investors. Founded by …See details»
SQZ Biotech - The Org
SQZ Biotech is a company founded out of the Massachusetts Institute of Technology (MIT). At SQZ they have developed a high-throughput platform - CellSqueeze - for simple and effective material delivery into cells. Industries. …See details»
SQZ Biotech - Funding, Financials, Valuation & Investors
SQZ Biotech is registered under the ticker NYSE:SQZ . Their stock opened with $16.00 in its Oct 29, 2020 IPO. SQZ Biotech is funded by 22 investors. National Institute of General Medical …See details»
SQZ Biotech - Craft
Sep 1, 2023 SQZ Biotech Summary. Company Summary. Overview. SQZ Biotechnologies is a company that develops cell therapies for patients with cancer and infectious diseases. It uses …See details»
SQZ Biotechnologies: Revenue, Worth, Valuation & Competitors …
About SQZ Biotechnologies. SQZ Biotechnologies is a Biotech related company founded in 2013 and based in Watertown with an estimated revenue of $17.2M, and 60 employees. It has 10 …See details»
SQZ Biotech is on Inc.'s 30 Under 30 List - Inc.com
May 24, 2016 SQZ Biotech. This young engineer landed $500 million to develop a new way to fight cancer. Company Information. Data as of Publication on May 24, 2016. Industry. Health …See details»
SQZ Biotechnologies Company Company Description - Stock …
Mar 24, 2025 Ticker Symbol: SQZB: Exchange: OTCMKTS: Stock Type: Common Stock: Fiscal Year: January - December: Reporting Currency: USD: ISIN Number: US78472W1045: SIC …See details»
SQZ Biotechnologies (USA) Funding: $229.8M - Medical Startups
USA | Funding: $229.8M Website: https://sqzbiotech.com SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies.See details»
SQZ opts for liquidation, $11.8M asset fire sale to Stemcell
Mar 1, 2024 Biotech SQZ, months after 80% layoffs, opts for liquidation and $11.8M asset fire sale to Stemcell By James Waldron Mar 1, 2024 10:20amSee details»
SQZ Biotech - Contacts, Employees, Board Members, Advisors
SQZ Biotech has 6 board members and advisors, including Eric Moessinger. Eric Moessinger Board Member. Klavs Jensen Board Member. Marc Elia Board Member. Zafrira Avnur Board …See details»
M&A: STEMCELL acquires SQZ Biotechnologies and Propagenix Inc
Mar 13, 2024 STEMCELL Technologies, Canada’s biotechnology company, announced the recent acquisition of substantially all assets of SQZ Biotechnologies (SQZ) and the Propagenix …See details»
SQZ Biotech | STEX - Startup
Apr 6, 2015 Meanwhile, at MIT and SQZ Biotech, research continues to help customize the device for different materials, cell types, and applications. It helped that the project had the …See details»
Company Spotlight - SQZ Biotechnologies - Illumina Ventures
On a quest to revolutionize cell therapy Cell therapies hold tremendous promise to treat cancer, autoimmune disorders and other conditions, but they are expensive and difficult to manufacture.See details»
SQZ Biotechnologies Company Overview, Contact Details
Mar 21, 2022 SQZ Biotech has issues with portfolio of over 400 patents and trademarks. In 2022, STEMCELL announced a collaboration with SQZ Biotechnologies, followed by the …See details»
SQZ Biotechnologies Company (SQZB) - Yahoo Finance Canada
Find the latest SQZ Biotechnologies Company (SQZB) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
SQZ Biotechnologies Company (SQZB) Stock Price & Overview
5 days ago Financial Performance. In 2022, SQZB's revenue was $21.48 million, a decrease of -20.74% compared to the previous year's $27.10 million. Losses were -$79.46 million, 15.6% …See details»